Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by slowing stomach emptying and signaling fullness in the brain, which means meaningful weight loss doesn't happen overnight. Most people taking semaglutide begin noticing appetite suppression within the first week, but the peak weight-loss window typically arrives during months two through four of consistent therapy.
Peak Weight Loss Timeline on Semaglutide
The heaviest weight loss on semaglutide generally occurs between weeks 8 and 16 of treatment, corresponding to months two and four. This timing aligns with the gradual dose-escalation phase most people follow, where the body adjusts to higher concentrations and appetite suppression becomes more pronounced. During this window, many patients report eating 30 to 50 percent fewer calories without conscious restriction, simply because hunger signals have weakened.
After month four, weight loss velocity often stabilizes rather than accelerates. This doesn't mean progress stops—it means your body has reached a new metabolic set point and continues losing weight at a steadier, sustainable rate. Some individuals experience a second wave of accelerated loss between months five and eight if they increase their dose or strengthen dietary adherence, but the dramatic drop typical of months two through four rarely repeats.
Timeline variation is normal and reflects differences in starting dose, escalation schedule, body composition, and how quickly your GLP-1 receptors respond. Someone beginning at a microdose may see peak loss delayed by one to two months compared to a patient starting at a standard-dose protocol. PlexusDx Semaglutide Injection, available from licensed 503A compounding pharmacies, allows personalized dose adjustments to match your individual response.
How Dose Escalation Affects Weight Loss Speed
Semaglutide requires a titration schedule—starting low and gradually stepping up every one to two weeks—because jumping to full dose causes nausea and gastrointestinal side effects that undermine compliance. This slow buildup is actually beneficial for weight loss consistency, as your body adapts progressively and appetite suppression deepens in stages. The first month often yields modest weight loss (five to ten pounds), but months two and three show significantly steeper drops once you've reached a therapeutically active dose.
Your dose may need to go up. Your price won't—PlexusDx Semaglutide Injection maintains a flat monthly rate regardless of which dose level your provider prescribes, so you're never penalized for finding the dose that works best for your metabolism. Patients who tolerate escalation well and reach higher therapeutic doses (0.5 to 1.0 mg weekly) tend to see their peak loss window earlier and sometimes more dramatically than those who remain at lower maintenance doses.
Genetic and Metabolic Factors That Shape Your Results
Not everyone's weight loss follows the same timeline because GLP-1 receptor sensitivity varies by genetics. Variants in the GLP1R gene (rs6923761) and related peptide pathways influence how strongly your body responds to semaglutide's appetite-suppressing signal. Someone with a genetic predisposition to heightened GLP1R sensitivity may hit their peak loss window in month two, while another person with lower receptor responsiveness might not see equivalent results until month four or five.
The Precision Peptide Genetic Test from PlexusDx maps 14 peptide pathways and analyzes variants like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 to reveal your individual weight-loss predispositions. This genetic insight, available as a $99 add-on after your first month of treatment, helps your provider fine-tune your dose and protocol timing rather than guessing whether you're a fast or slow responder. Patients with genetic markers favoring rapid GLP-1 response often experience their steepest loss during months two and three, while those with metabolic variants requiring longer adaptation may see peak loss shift toward month four or five.
Sustaining Weight Loss Beyond the Peak Month
The months following your peak-loss window remain critical because maintaining the habits you've built—smaller portions, protein-focused eating, regular movement—determines whether weight loss continues or plateaus. Many patients mistakenly assume weight loss will plateau after month four, but research shows consistent, meaningful loss continues through month twelve if medication adherence and lifestyle remain steady. The rate becomes more gradual (one to two pounds weekly instead of three to five), but total weight loss by month twelve often reaches 15 to 25 percent of starting weight.
If weight loss slows dramatically after month four, your provider may recommend a dose increase, dietary adjustment, or assessment for medication adherence issues. Some patients benefit from adding complementary therapies—like the Microdose GLP-1 Protocol at $129 monthly—or exploring dual-compound options like GLP-Squared Injection for enhanced peptide signaling. PlexusDx Semaglutide Injection, starting at $149 monthly with no insurance required, can be combined with lifestyle coaching and genetic insights to keep momentum steady through month twelve and beyond.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Which month shows the biggest weight loss on semaglutide?
Most patients experience their steepest weight loss between months two and four, as dose escalation reaches therapeutic levels and appetite suppression intensifies. Individual timing varies based on starting dose, genetic GLP-1 sensitivity, and how quickly your body adjusts to the medication.
Why is month one weight loss slower than month two or three?
Month one uses low starting doses to allow tolerance and minimize side effects. By month two, you've typically reached a higher therapeutic dose, and your GLP-1 receptors have adapted, producing stronger appetite suppression and faster weight loss. This gradual escalation prevents nausea while building sustainable results.
Is it normal for weight loss to slow down after month four?
Yes. After the initial rapid phase, weight loss naturally becomes more gradual as your body reaches a new metabolic set point. This doesn't signal failure—many patients continue losing one to two pounds weekly through month twelve. If loss stalls completely, your provider may adjust your semaglutide dose or explore options like PlexusDx's GLP-Squared dual-compound injection.
Does PlexusDx pricing change if my semaglutide dose increases?
No. PlexusDx Semaglutide Injection maintains a flat monthly rate starting at $149, regardless of your dose level. Your dose may need to go up. Your price won't. This transparent pricing applies across all three commitment tiers and eliminates surprise costs as your treatment advances.
Can genetic testing predict when my peak weight loss will occur?
The Precision Peptide Genetic Test ($99 add-on) analyzes variants like GLP1R rs6923761 and FTO rs9939609 to reveal your metabolic predispositions. Patients with genetic markers favoring rapid GLP-1 response often hit their peak loss window in months two to three, while others may see it shift to month four or five. This insight helps your provider optimize your dose timing for faster, personalized results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Should You Take Tirzepatide With Food? Optimizing Your Weight Loss Journey
Which is Better: Oral or Injectable Semaglutide?